Funding Opportunities

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NIH-funded Brain Vascular Malformation Consortium (BVMC, U54 NS065705) is soliciting proposals for a one-year pilot project proposal. Proposals should focus on the following rare diseases and/or related outcomes in cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT).

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: Proposals will be reviewed by the BVMC Executive Steering Committee and selected for funding based on the following criteria: clinical research potential in rare diseases, potential to enhance clinical trial readiness for any of the three BVMC diseases; thematic relationship to the aims and scope of the BVMC; scientific quality of the proposal; leverage existing BVMC (and RDCRN) resources and infrastructure, especially patient registries/databases; feasibility in projected time frame; ability to support promising junior investigators; ability to seed new collaborations that might lead to novel research concepts or therapeutic approaches; and ability to seed new collaborations that might lead to new grant proposals.

Application Due Date: 2023-03-17

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The NIH-funded Brain Vascular Malformation Consortium (BVMC, U54 NS065705) is soliciting applications to support clinical/translational investigators who focus on the study of rare neurovascular diseases, including: cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT).

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: We are seeking to support advanced post-doctoral or clinical fellows, junior faculty, or established investigators who wish to develop or refocus their careers on clinical research in rare diseases. Under exceptional circumstances, we will consider applications from medical and graduate students proposing year-long projects. BVMC scholars should choose a mentor and research project aligned with one or more of the three BVMC Projects at cooperating institutions. There is wide breadth and depth of expertise spread across the BVMC that provides a rich research and mentoring environment.

Application Due Date: 2023-03-17

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To initiate and support collaborative research on osteogenesis imperfecta (OI).

Sponsor: Brittle Bone Disorders Consortium (BBD)

Eligibility Criteria: Both internal and external investigators are encouraged to propose and conduct pilot studies.

Application Due Date: 2024-01-01

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Michael Geisman Fellowship Grant program awards funding to post-doctoral trainees who are currently working on projects with clear relevance to osteogenesis imperfecta (OI), or who have projects that will enable them to develop expertise in OI research.

Sponsor: Osteogenesis Imperfecta Foundation

Eligibility Criteria: Applicant must hold an MD, DDS, DO, or PhD, and be appointed at the level of a post-doctoral trainee, or equivalent, within an academic institution. Applicant should have completed their Ph.D. or clinical training within the past five (5) years.

Application Due Date: 2024-10-21

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]).

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | ALS Association

Eligibility Criteria: Any individual with the requisite scientific training, irrespective of country of residence or origin. Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.

Application Due Date: 2021-07-30

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: This award aims to support young investigators engaged in clinical research focused on ALS, ALS-FTD, PLS, PMA, and HSP.

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | American Brain Foundation

Eligibility Criteria: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.

Application Due Date: 2023-09-14

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The goal of this training award is to support the development of future researchers in pediatric antimicrobial stewardship by providing mentorship to complete a scholarly research project in a timely manner during clinical or research training. Applicants may propose a research study that focuses on any aspect of antimicrobial stewardship. The project should be able to be completed in one year. Projects spanning more than one year will be considered if a portion of the project that answers a specific research question can be completed within the year timeframe.

Sponsor: ediatric Infectious Diseases Society (PIDS) and Pediatric Committee on Antimicrobial Stewardship (PCAS)

Eligibility Criteria: Candidates must be enrolled in a training program, which can encompass any number of disciplines, such as medical residency or fellowship, pharmacy residency, or graduate education. Interested applicants from fields or programs not specified above are encouraged to contact PIDS to discuss eligibility at pids@idsociety.org. Applicants must join PIDS prior to application.

Application Due Date: 2024-06-21

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The APA Collaborative Research Network Young Investigator Award (APA-CRN YIA) provides support to young investigators who propose a study to be implemented within at least one of the three APA research networks: BORN, CORNET, and PRIS.

Sponsor: Academic Pediatric Association

Eligibility Criteria: The principal investigator and his/or chosen mentor(s) of each submitted proposal must be members of the Academic Pediatric Association.

Application Due Date: 2024-10-01

Opportunity Type: Education and Career Development Opportunities

Goal: The APA YIA Funding Path supports projects in health services research, medical education, adolescent medicine, public health, epidemiology, emergency medicine, child maltreatment, hospital medicine, developmental/behavioral pediatrics, and other general pediatric clinical research domains. The YIA Program is particularly interested in proposals that address health equity.

Sponsor: Academic Pediatric Association

Eligibility Criteria: The young investigator and his/her/their chosen mentor(s) must be members of the Academic Pediatric Association.

Application Due Date: 2024-10-01

Term: Annual

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Projects to eliminate the disease burden associated with rare pediatric viral diseases focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and human parechovirus (HPeV) sepsis.

Sponsor: Congenital and Perinatal Infections Consortium (CPIC)

Eligibility Criteria: This program is primarily intended to support full-time faculty who are early-stage investigators (see NIH definition). Faculty with previous or active K-awards are eligible and are encouraged to apply. Past CPIC pilot applicants are also encouraged, but subsequent applications should be “new” submissions. Postdoctoral fellows are eligible if a faculty appointment will be made on or before September 1, 2024. If this is the case, the applicant must include a letter from their Department Chair confirming their status. Applications will also be accepted from established investigators with a previous history of funding with justification of eligibility. Established investigators are eligible if the proposed research represents a major shift from his/her scientific portfolio to date. By providing an Eligibility Statement within the Pre-Application, established PIs have the opportunity to comment on how the proposed aims represent a major shift in science.

Letter of Intent Due Date: 2024-04-15

Application Due Date: 2024-06-05

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: Program impacts the research career development of the next generation of rare diseases researchers focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and parechovirus (HPeV) sepsis.

Sponsor: Congenital and Perinatal Infections Consortium (CPIC)

Eligibility Criteria: Open to interested fellows and early-stage faculty.

Application Due Date: Applications accepted on a rolling basis.

Term: One - Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: The PIDS Foundation has created an International Medical Graduate (IMG) Early Career Development Award designed to provide bridge financial support to IMGs as they transition from fellow to faculty.

Sponsor: PIDS Foundation

Eligibility Criteria: Candidates must possess a MD, MD/PhD, DO or equivalent from a non-U.S. medical school. At the time of application, candidates may: be in the final year of a pediatric ID fellowship, have completed an ID fellowship, and are in the final year of a general pediatric residency program, be within the first 2 years of their first appointment in pediatric infectious diseases after training completion. Current fellows and residents should have a planned primary appointment (accepted job offer) in pediatric infectious diseases. Applicants must be a current PIDS member at the time of application.

Application Due Date: 2024-01-15

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The National CMV Foundation is pleased to fund innovative research related to maternal or congenital cytomegalovirus (CMV) infections.

Sponsor: National CMV Foundation

Eligibility Criteria: Priority will be given to early career researchers including mentored pre- and post-doctoral trainees or junior faculty members who have not been a principal investigator (PI) on a National Institutes of Health (NIH) grant. Trainee applicants must provide a letter of support and a mentoring plan from the Mentor. Mid-career researchers may be considered if congenital CMV is a new area for their research. Applications will be accepted from researchers in the United States and Canada.

Application Due Date: 2024-07-31

Term: 12 or 24 months, non-renewable

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The award is intended to support translational and clinical research involving vaccine development and/or pathogenesis or host-pathogen interaction moves the field towards the development of new vaccines and therapeutics. Studies of new uses of existing vaccines (e.g., use in a special population) may also be considered; however, preference will be made for studies that advance new knowledge, new insights into vaccine and immunotherapeutic development, pathogenesis and host-pathogen interactions. Research proposals that focus principally on disease surveillance or vaccine attitudes/hesitancy are unlikely to be funded.

Sponsor: Pichichero Family Foundation

Eligibility Criteria: Pediatric infectious diseases physicians and scientists (MD and/or PhD) are encouraged to apply. All applicants must be members of PIDS. Established investigators should provide evidence for how the proposed work represents a new direction that is not currently or previously funded.

Application Due Date: Applications accepted on a rolling basis.

Term: 2 years

Opportunity Type: Education and Career Development Opportunities

Goal: The award is intended to support scholarship in pediatric infectious diseases broadly, including basic science, translational, clinical, epidemiology, and quality improvement research. Given the brevity of the summer research experience, focused studies or well-defined contributions to larger research projects will be most successful.

Sponsor: Sanofi Pasteur

Eligibility Criteria: Eligible research involving: basic science, translational, clinical, epidemiology, quality improvement

Application Due Date: 2024-03-25

Term: Summer

Opportunity Type: Education and Career Development Opportunities

Goal: RAPID Scholar Awards Home / Programs & Awards / Research Funding Programs / RAPID Scholar Awards RAPID’s Scholar Awards awards target applicants (junior faculty and fellows in their last year of fellowship) who identify as underrepresented in medicine (UIM), or disabled.

Sponsor: Academic Pediatric Association

Eligibility Criteria: If applying for the NIDDK pathway, confirm that both the principal investigator and his/her chosen mentor(s) are current members of the Academic Pediatric Association; if applying for the PIDS pathway, confirm that both the principal investigator and his/her chosen mentor(s) are current members of PIDS. Applicants must identify as underrepresented in medicine (UIM), or disabled, who are committed to a career in academic general pediatrics. Proposals are welcome from those who are: fellows in the last year of fellowship, faculty members no more than 5 years out from completion of all training (fellowship or post-doc). Previous RAPID Scholars and YIA recipients are not eligible to apply.

Application Due Date: 2024-11-01

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The goal of these programs is to foster the academic career development of physicians in Pediatric Infectious Diseases. Applicants are encouraged to pursue opportunities to conduct cutting-edge clinical, translational, and basic science research in fields such as public health, epidemiology, antimicrobial stewardship, health disparities, infection control, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, vaccine development, and other fields relevant to Pediatric Infectious Diseases.

Sponsor: Stanley and Susan Plotkin and Sanofi Pasteur

Eligibility Criteria: Candidates must possess a MD, MD/PhD, DO or equivalent and be a first or secondyear fellow in a Pediatric Infectious Diseases program in North America at the time of application. During the fellowship award period, the applicant is expected to devote the majority of effort (approximately 75%) conducting the research project under the direct supervision of a mentor. The primary or co-mentor must be a current PIDS member.

Application Due Date: 2024-04-01

Term: Total costs per year for 2 years

Opportunity Type: Education and Career Development Opportunities

Goal: The goal of these programs is to foster the academic career development of physicians in Pediatric Infectious Diseases. Applicants are encouraged to pursue opportunities to conduct cutting-edge clinical, translational, and basic science research in fields such as public health, epidemiology, antimicrobial stewardship, health disparities, infection control, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, vaccine development, and other fields relevant to Pediatric Infectious Diseases.

Sponsor: Stanley and Susan Plotkin and Sanofi Pasteur

Eligibility Criteria: Candidates must possess an MD or an MD/PhD or equivalent and be a first-year fellow in an accredited pediatric infectious diseases fellowship training program in North America. During the fellowship award period (July 1, 2024-2-June 20, 2027), the applicant is expected to devote the majority of effort conducting the research project under the direct supervision of a mentor –approximately 75% during the first year of support, increasing to approximately 90% during the subsequent 2 years.

Application Due Date: 2024-04-01

Term: 3 years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To allow CEGIR investigators to initiate new projects relevant to eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), eosinophilic enteritis (EoN), and/or eosinophilic colitis (EoC).

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: MD, DO, PhD, or MD/PhD who is a member of CEGIR and full-time faculty at an academic institution in the USA or NIH

Application Due Date: Applications accepted on a rolling basis.

Term: One - Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: To train experts to investigate eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, physicians, patients, and professional organizations.

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applicants must be physicians trained in Internal Medicine, Pediatrics or Pathology with ongoing or completed subspecialty training (within 5 years of award start date) in a related field in an ACGME-accredited training program. Candidates should be US citizens, US permanent residents, or possess a valid visa to work in the US.

Application Due Date: Applications accepted on a rolling basis.

Term: Three Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the PFC is to serve as an engine and source of funding support for translational research across these three rare brain disorders to further our understanding of biological processes and development of novel therapies. The PFC aims to support collaboration across disciplines and take advantage of key infrastructure across the consortium to drive research that enhances not only clinical understanding but also bolsters community education and family engagement, in order to accelerate development of new therapies.

Sponsor: Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Applications will be accepted from investigators interested in research on TSC, PHTS and PMS disorders or research across these and/or related disorders.

Application Due Date: 2023-04-15

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: To support development in characterizing the developmental alterations associated with PTEN variants.

Sponsor: Developmental Synaptopathies Consortium (DSC) | PTEN Research Foundation

Eligibility Criteria: This opportunity is open to all investigators eligible to work at any of the Developmental Synaptopathies Consortium PHTS sites: Boston Children’s Hospital, Cleveland Clinic, Cincinnati Children’s Hospital, Stanford University and University of California, Los Angeles. If not located at a DSC site as above: the applicant can either identify an investigator from one of the DSC sites with complementary research interests or propose an experimental plan to be matched with the appropriate mentor by the DSC. Applicant’s institution is where the proposed work will take place.

Application Due Date: 2021-07-02

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: To help characterize neuropsychiatric phenotypes in patients with Phelan-McDermid syndrome (PMS).

Sponsor: Phelan-McDermid Syndrome Foundation (PMSF) | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Highly qualified postdoctoral applicants with an MD, PhD, or MD/PhD, for the Phelan-McDermid Syndrome Foundation/Developmental Synaptopathies Consortium Young Investigator Fellowship. The ideal candidate has a clinical and/or research background in psychiatry, psychology, or neurology with a focus on neurodevelopmental disorders, and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-01-14

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: The fellow will work within the NIH-funded Developmental Synaptopathies Consortium (DSC), a project within the Rare Disease Clinical Research Network (RDCRN), under the training of leaders in the field with a pre-established infrastructure for recruiting and phenotyping large numbers of patients with this rare disorder. Areas of potential research include, but are not limited to: iPSC derived neuronal modeling of TSC, characterization of the natural history of TSC, and development of endpoints for clinical trials in TSC.

Sponsor: TS Alliance | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: MD, PhD, or MD/PhD applicants. The ideal candidate has a clinical or research background in either TSC biology or neurodevelopmental disorders and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-03-15

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: A mentored award designed to provide "protected time" for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. A long-term goal is to establish a Leukodystrophy Center at each award recipient’s local institution. The award supports a period of supervised research, in conjunction with career development opportunities, for physician-scientists who require additional mentored training and support during development of an innovative research project.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible, outlined below. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-20

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-21

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet)

Eligibility Criteria: Applicants must have a MD (or equivalent) or PhD clinical fellows, post-doctoral fellows, or junior faculty are eligible. Applicants must identify a primary mentor with appropriate content expertise and experience mentoring young investigators. Candidates should be US citizens, US permanent residents, or non-US citizens with a valid visa to work in the US. MGNet Scholars do not have be at a MGNet site.

Application Due Date: 2024-10-01

Term: One year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Pilot studies must be designed to access the resources of MGNet and focused on clinical research, including fulfilling the definition of clinical research and exclusion of animal studies.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet) | Myasthenia Gravis Foundation of America | Conquer MG

Eligibility Criteria: The PI must hold an MD, PhD, MD/PhD, RN or more advanced, PharmD, DDS, DVM, or equivalent and be a faculty member at an academic institution.

Application Due Date: 2023-10-01

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: We are soliciting applications for the North American Mitochondrial Disease Consortium (NAMDC) fellowship. This NIH funded 1 year fellowship will provide a unique clinical trials training opportunity for a senior fellow who will be trained to practice mitochondrial medicine.

Sponsor: National Institutes of Health

Eligibility Criteria: Clinicians, Senior Post-Doctoral Non-MD Scientists

Application Due Date: Applications accepted on a rolling basis.

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution. Applicants will be considered from both the United States and internationally.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

Opportunity Type: Education and Career Development Opportunities

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals, promote and encourage young investigators into PKU-related research, to close the existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and have an opportunity to hold a full-time fellowship position at an established academic/research institution. Both United States and international academic institutions will be considered.

Application Due Date: 2022-05-01

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the PHEFREE pilot/feasibility program is to provide funding for studies of innovative ideas or hypotheses which, if successful, could lead to improvement in the understanding, prevention, diagnosis and/or treatment of hyperphenylalaninemia, biopterin defects and related conditions.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: MD, PhD, or MD/PhD investigators are eligible to apply.

Application Due Date: 2023-01-06

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The primary mission of this program is to train and attract new investigators to research on hyperphenylalaninemia, biopterin defects and related conditions that is directly relevant to improvement in patient care, treatment and quality of life.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2023-01-06

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To provide funding for pilot projects or feasibility projects that take maximum advantage of new clinical research opportunities in UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Anyone conducting UCD research is eligible. Must have a UCDC sponsor or we can help identify one, if needed. Only one application can be submitted from each UCDC site/institution.

Application Due Date: 2021-02-22

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: To train and attract new investigators who will conduct research in urea cycle disorders (UCDs) that contribute to a better understanding of UCDs and help improve the treatment and quality of life for individuals with UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2023-04-17

Term: One Year